Johns Hopkins cancer diagnostics spinoff Thrive Earlier Detection Corp. has raised $257 million in new funding a little over a year after it closed another huge round.
Thrive launched in May 2019 with $110 million in funding for its cancer-detecting blood test developed by researchers at Johns Hopkins. That Series A round was remarkable for its size. It was the largest ever raised in support of a Hopkins-licensed technology, and among the largest raised by any firm co-based in the Baltimore area.
Image: https://www-bizjournals-com
{iframe}https://www-bizjournals-com.cdn.ampproject.org/c/s/www.bizjournals.com/baltimore/news/2020/07/29/thrive-earlier-detection-raises-funding-round.amp.html{/iframe}